KCNA6

Across TCGA pan-cancer cohorts, KCNA6 RNA is linked to patient survival in 1 of 34 cancer types, making it a survival-associated KCNA6 data layer compared with 11 for mutation status.

The strongest signal is observed in small cell lung cancer (SCLC), where higher KCNA6 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KCNA6 expression acts as an unfavorable survival marker, although some lineages such as SCLC show a favorable association.

SCLC are the cancer types where KCNA6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	DFS	Median	III,IV	0.496	0.256	.036	5	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

KCNA6–SCLC (DFS)

Open the SCLC breakdown →